Methamphetamine in Afghanistan: Assessing Changes to Participation and Production

Add bookmark


We respect your privacy, by clicking "Download Your Copy" you will receive our e-newsletter, including information on Podcasts, Webinars, event discounts, online learning opportunities and agree to our User Agreement. You have the right to object . In addition, you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest subject to their privacy policy. For further information on how we process and monitor your personal data click here. You can unsubscribe at any time.

As part of our partnership with Maxar Technologies, Defence iQ is pleased to publish this latest issue of Maxar Spotlight. The report examines the propagation of methamphetamine labs in Afghanistan and the use of advanced earth imaging and remote sensing capabilities to detect and quantify meth production.

Maxar Technologies' advanced geospatial capabilities and unique subject matter expertise were used in several key locations to identify trends and suggest possible ways to detect and quantify meth production in Afghanistan. This edition was produced in collaboration with Dr. David Mansfield and Alcis, whose field work in Afghanistan has given them valuable insight into the rapidly evolving situation on the ground.

With Afghanistan as a case study, read this edition of "Spotlight - Methamphetamine in Afghanistan: Assessing Changes to Participation and Production" to find out about:

  • How analysts leveraged sophisticated Maxar earth imaging and remote sensing capabilities to locate areas in central Afghanistan where ephedra was most likely recently harvested.
  • Through proprietary crowdsourcing, vetted users validated, discovered and annotated features of interest such as newly constructed methamphetamine labs.

To understand how emerging technologies like AI and machine learning are enhancing geospatial intelligence collection and exploitation, visit Maxar's website here.

To continue reading this story get free access

RECOMMENDED